NPS Pharma (NPSP) Halted Ahead of FDA Committee Meeting for Gattex
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- US stock futures fall as fading Iran peace prospects drive up oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
NPS Pharmaceuticals (NPSP) Mildly Higher after FDA Backing
October 16, 2012 4:21 PM EDTNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) resumes after FDA panel backing for Gattex. Shares are currently up about 1% to $10.29.... More
NPS Pharmaceuticals (NPSP) to resume trading at 4:20PM
October 16, 2012 4:19 PM EDTNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) to resume trading at 4:20PM after FDA panel backing for Gattex.... More
FDA Says NPS Pharma's (NPSP) Gattex has 'Clinically Meaningful' Benefit
October 16, 2012 2:14 PM EDTNPS Pharmaceuticals' (NASDAQ: NPSP) Gattex had clinically meaningful benefit for short bowel, according to the FDA.... More
NPS Pharmaceuticals, Inc. (NPSP) halted, news pending
October 16, 2012 7:01 AM EDTNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) halted, news pending... More
NPS Pharmaceuticals (NPSP) On Watch With FDA Briefing Documents Posted
October 12, 2012 8:14 AM EDTShares of NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) are on watch with FDA briefing documents posted for the October 16, 2012 Gastrointestinal Drugs Advisory... More
